Hailey-Hailey disease treated with dupilumab: a case series

Br J Dermatol. 2021 Sep;185(3):680-682. doi: 10.1111/bjd.20475. Epub 2021 Jul 5.

Authors

N Alzahrani¹, J Grossman-Kranseler², R Swali³, K Fiumara⁴, P Zancanaro², S Tyring⁵, D Rosmarin²

Affiliations

¹ King Abdulaziz University, Jeddah, Saudi Arabia.
² Department of Dermatology, Tufts Medical Center, Boston, MA, USA.
³ Center for Clinical Studies, Houston, TX, USA.
⁴ Clinical Pharmacy, Tufts Medical Center, Boston, MA, USA.
⁵ McGovern Medical School at University of Texas Health Science Center, Houston, TX, USA.

PMID: 33971025
DOI: 10.1111/bjd.20475

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Antibodies, Monoclonal, Humanized
Humans
Pemphigus, Benign Familial* / drug therapy

Substances

Antibodies, Monoclonal, Humanized
dupilumab